JPWO2023283644A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2023283644A5 JPWO2023283644A5 JP2024500475A JP2024500475A JPWO2023283644A5 JP WO2023283644 A5 JPWO2023283644 A5 JP WO2023283644A5 JP 2024500475 A JP2024500475 A JP 2024500475A JP 2024500475 A JP2024500475 A JP 2024500475A JP WO2023283644 A5 JPWO2023283644 A5 JP WO2023283644A5
- Authority
- JP
- Japan
- Prior art keywords
- polynucleotide
- seq
- sequence
- encoding
- trop
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163220283P | 2021-07-09 | 2021-07-09 | |
| US63/220,283 | 2021-07-09 | ||
| PCT/US2022/073566 WO2023283644A2 (en) | 2021-07-09 | 2022-07-08 | Chimeric antigen receptor to target trop-2-positive cancers |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024525609A JP2024525609A (ja) | 2024-07-12 |
| JPWO2023283644A5 true JPWO2023283644A5 (https=) | 2025-07-07 |
| JP2024525609A5 JP2024525609A5 (https=) | 2025-07-07 |
Family
ID=84802126
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024500475A Pending JP2024525609A (ja) | 2021-07-09 | 2022-07-08 | Ｔｒｏｐ－２陽性癌を標的とするキメラ抗原受容体 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20240325444A1 (https=) |
| EP (1) | EP4366747A4 (https=) |
| JP (1) | JP2024525609A (https=) |
| KR (1) | KR20240034220A (https=) |
| CN (1) | CN117881407A (https=) |
| AU (1) | AU2022306051A1 (https=) |
| CA (1) | CA3224887A1 (https=) |
| IL (1) | IL309497A (https=) |
| MX (1) | MX2024000479A (https=) |
| WO (1) | WO2023283644A2 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN118265535A (zh) * | 2021-10-20 | 2024-06-28 | 得克萨斯大学体系董事会 | 具有最佳信号传导的car构建体的工程化nk细胞 |
| GB202318553D0 (en) * | 2023-12-05 | 2024-01-17 | Unikum Therapeutics Aps | Engineered plasmacytoid dendritic cells |
| WO2025194098A1 (en) * | 2024-03-14 | 2025-09-18 | Dana-Farber Cancer Institute, Inc. | Engineered immune cells expressing chimeric antigen receptors targeting trop2, and methods of using the same |
| CN119215188B (zh) * | 2024-04-12 | 2025-09-05 | 英百瑞(杭州)生物医药有限公司 | 抗Trop2抗体和抗5T4抗体-自然杀伤细胞偶联物及其用途 |
| CN118307680A (zh) * | 2024-04-28 | 2024-07-09 | 华南农业大学 | 一种抗氯霉素单克隆抗体及其基于磁珠的自动化化学发光酶免疫检测方法与应用 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003074566A2 (en) * | 2002-03-01 | 2003-09-12 | Immunomedics, Inc. | Rs7 antibodies |
| JP2018500930A (ja) * | 2014-12-04 | 2018-01-18 | アブルッツォ・セラノスティックス・エッセ・エッレ・エッレ | ヒト化抗ｔｒｏｐ−２モノクローナル抗体及びその使用 |
| CN107708741A (zh) * | 2015-06-12 | 2018-02-16 | 免疫医疗公司 | 用嵌合抗原受体(car)构建体和表达car构建体的t细胞(car‑t)或nk细胞(car‑nk)进行的疾病疗法 |
| US11951131B2 (en) * | 2018-07-03 | 2024-04-09 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Anti-SLAMF7 chimeric antigen receptors |
| BR112021003640A2 (pt) * | 2018-08-31 | 2021-05-18 | Noile-Immune Biotech, Inc. | célula t, medicamento, vetor de expressão, e, métodos para produzir uma célula de t car e para tratar câncer |
| SG11202104524YA (en) * | 2018-11-01 | 2021-05-28 | Gracell Biotechnologies Shanghai Co Ltd | Compositions and methods for t cell engineering |
| WO2023232746A1 (en) * | 2022-05-30 | 2023-12-07 | Mediterranea Theranostic S.R.L. | Anti-activated trop-2 chimeric antigen receptor constructs for use in cancer therapy |
-
2022
- 2022-07-08 EP EP22838607.4A patent/EP4366747A4/en active Pending
- 2022-07-08 JP JP2024500475A patent/JP2024525609A/ja active Pending
- 2022-07-08 US US18/574,539 patent/US20240325444A1/en active Pending
- 2022-07-08 CA CA3224887A patent/CA3224887A1/en active Pending
- 2022-07-08 IL IL309497A patent/IL309497A/en unknown
- 2022-07-08 WO PCT/US2022/073566 patent/WO2023283644A2/en not_active Ceased
- 2022-07-08 AU AU2022306051A patent/AU2022306051A1/en active Pending
- 2022-07-08 MX MX2024000479A patent/MX2024000479A/es unknown
- 2022-07-08 CN CN202280059099.5A patent/CN117881407A/zh active Pending
- 2022-07-08 KR KR1020247004709A patent/KR20240034220A/ko active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2022204601B2 (en) | Methods for enhancing efficacy of therapeutic immune cells | |
| JP2020513839A5 (https=) | ||
| JP2020517295A5 (https=) | ||
| JP2017524367A5 (https=) | ||
| KR20210111244A (ko) | 태반-유래 동종이계 car-t 세포 및 이의 용도 | |
| JPWO2023283644A5 (https=) | ||
| JPWO2022216514A5 (https=) | ||
| JPWO2022216624A5 (https=) | ||
| WO2024193714A1 (zh) | 细胞免疫疗法的组合物和方法 | |
| JPWO2021142127A5 (https=) | ||
| JPWO2023278520A5 (https=) | ||
| JPWO2021055349A5 (https=) | ||
| JPWO2023004425A5 (https=) | ||
| JPWO2022159791A5 (https=) | ||
| IL313388A (en) | Chimeric antigen receptor-modified cells for the treatment of CLDN6-expressing cancer | |
| KR20260036568A (ko) | 세포 면역 요법용 조성물, 및 방법 | |
| HK40086170A (en) | Methods for enhancing efficacy of therapeutic immune cells | |
| EP4714981A1 (en) | Immune effector cell and use thereof | |
| WO2025213573A1 (zh) | 细胞免疫疗法的组合物和方法 | |
| HK40077730B (zh) | 核酸、包含其的工程免疫细胞及其制备方法和用途 | |
| RU2021126229A (ru) | Модифицированные клетки с химерным антигеновым рецептором для лечения рака, экспрессирующего CLDN6 | |
| HK1248273B (en) | Methods for enhancing efficacy of therapeutic immune cells | |
| HK1248273A1 (en) | Methods for enhancing efficacy of therapeutic immune cells |